Yan Ming's Form 4 filing
Cytek Biosciences, Inc. (CTKB) · filed Nov 22, 2022
- Accession no.
- 0001209191-22-058474
- Filed
- Nov 22, 2022
- Trade date
- Nov 18-21, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $293.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yan MingCIK 0001874041 | Director, Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Common Stock | MOption exerciseAcquired | +1,981 | – | – | 8,007,605 | Direct | |
| Nov 18, 2022 | Common Stock | FTax withholdingDisposed | −772 | $14.75 | −$11,387 | 8,006,833 | Direct | |
| Nov 21, 2022 | Common Stock | SSaleDisposed | −20,000 | $14.66 | −$293,200 | 7,986,833 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Common Stock | MOption exerciseDisposed | −1,981 | $0.00 | $0 | 25,104 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.